Skip to main content
. 2023 Oct 17;13:17627. doi: 10.1038/s41598-023-45013-6

Table 3.

Demographics, clinical parameters and outcomes of ICU-admitted patients eligible for VV-ECMO by EOLIA, ELSO, NSW, CCSO and Regina-restrictive criteria.

EOLIA criteria (n = 7) ELSO criteria (n = 6) NSW (n = 19) CCSO criteria (n = 26) Regina-restrictive criteria (n = 12)
Criteria met, N (%) 7 (1.7%) 6 (1.5%) 19 (4.6%) 26 (6.3%) 12 (2.9%)
Age, median years (IQR) 67 (54–70) 49 (31–69) 63 (44–73) 67 (54–73) 61 (52–70)
Male gender, N (%) 4 (57.1%) 6 (100%) 16 (84.2%) 19 (73.1%) 10 (83.3%)
Charlson Comorbidity Index, median score (IQR) 1 (0–3) 1.5 (1–3) 2 (0–5) 1 (0–2) 1 (0–2)
Sequential Organ Failure Assessment, median score (IQR) 10 (7–13) 11 (8–13) 8 (7–11) 8 (5–10) 8 (6–9)
Clinical Frailty Score (IQR) 3 (2–4) 2 (2–2) 3 (2–3) 3 (2–4) 3 (3–4)
Body Mass Index, median kg/m2 (IQR) 29 (26–31) 32 (30–46) 28 (24–32) 30 (28–41) 29 (27–35)
Need for dialysis, N (%) 2 (28.6%) 0 (0%) 3 (15.8%) 3 (11.5%) 0 (0%)
COVID-19, N (%) 1 (14.3%) 3 (50.0%) 2 (10.5%) 5 (19.2%) 4 (33.3%)
Set VT, median mL/kg (IQR) 7.7 (7.4–8.2) 7.4 (6.8–7.7) 7.3 (7.0–7.6) 7.8 (7.3–8.6) 7.0 (6.0–7.9)
Actual delivered VT, median mL/kg (IQR) 8.2 (8.0–8.9) 8.7 (7.0–10.4) 8.8 (7.2–10.2) 8.6 (8.0–10.4) 8.6 (6.4–10.4)
Prone positioning, N (%) 3 (42.9%) 5 (83.3%) 9 (47.4%) 12 (46.2%) 7 (58.3%)
Neuromuscular blockade, N (%) 4 (57.1%) 5 (83.3%) 10 (52.6%) 12 (46.2%) 8 (66.7%)
Nitric oxide, N (%) 2 (28.6%) 1 (16.7%) 2 (10.5%) 3 (11.5%) 2 (16.7%)
Hospital length of stay, median days (IQR) 8 (1–10) 1 (1–9) 12 (2–25) 19 (10–25) 15 (9–20)
ICU length of stay, median days (IQR) 3 (1–10) 1 (1–9) 8 (1–13) 13 (3–22) 13 (9–18)
In-hospital mortality, N (%) 6 (83.7%) 5 (83.3%) 12 (63.2%) 14 (53.9%) 9 (75.0%)

CCSO Critical Care Services Ontario, COVID-19 Coronavirus-19, ELSO Extracorporeal Life Support Organization, EOLIA Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome, ICU intensive care unit, IQR interquartile range, NSW New South Wales, VT tidal volume, VV-ECMO veno-venous extracorporeal membrane oxygenation.